Why Synergy Pharmaceuticals, Tesla, Tencent and More Are Trending
The markets are in the red again on Friday as all three major indexes are down by over 1%.
Synergy Pharmaceuticals Inc. (SGYP)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Fisher Asset Management Ken Fisher | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $3.59 | 6,500 | $23,335.00 | 30,444 | 2017-05-26 | Filing | |
| $3.52 | 5,680 | $19,967.47 | 402,679 | 2017-05-26 | Filing | |
| $4.12 | 3,500 | $14,420.00 | 23,944 | 2014-06-03 | Filing | |
| $4.18 | 4,000 | $16,720.00 | 338,034 | 2014-05-27 | Filing | |
| $3.89 | 2,500 | $9,725.00 | 12,952 | 2014-05-23 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $2.82 | 8,750,000 | $24,678,500.00 | 15,312,368 | 2017-11-10 | Filing | |
| $3.77 | 26,200 | $98,643.00 | 24,062,368 | 2017-08-07 | Filing | |
| $3.78 | 87 | $328.86 | 24,088,568 | 2017-08-07 | Filing | |
| $4.24 | 140,000 | $593,936.00 | 24,088,655 | 2016-11-04 | Filing | |
| $5.60 | 20,700 | $116,004.87 | 24,228,655 | 2016-09-28 | Filing |
Institutional Investors' Holdings
News See All
13G Filing: Paulson & Co and Synergy Pharmaceuticals Inc. (SGYP)
*The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing ...
15 Penny Stocks Poised To Explode According To Hedge Funds
Penny stocks are usually defined as shares of small companies that trade under $1 per share, although the SEC defines a penny stock as a security that trades under $5 per share. There are thousands or...
Why President Trump Wants To Transform The FDA - And What It Could Mean For Biotech Stocks
A few weeks ago, President Donald Trump met with a series of biotech CEOs to discuss a historically major pain point for the industry: cutting the FDA drug approval process "at a level no one has ever...
Price For Synergy Pharmaceuticals Inc (SGYP) Public Offering Announced
Synergy Pharmaceuticals Inc (NASDAQ:SGYP) has revealed that the price of its common stock through its upcoming public offering will be $6.15 a share.
FDA Approves Trulance From Synergy Pharmaceuticals Inc (SGYP) To Battle With Allergan PLC (AGN) Linzess
The chronic idiopathic constipation (CIC) market has a new entrant. This was occasioned by the FDA’s approval of Trulance from Synergy Pharmaceuticals Inc (NASDAQ:SGYP).
Synergy Pharmaceuticals Inc (SGYP): A Top January Pick Ahead Of PDUFA
Synergy Pharmaceuticals Inc (NASDAQ:SGYP) has gradually picked up strength over the last six months or so, as the company creeps towards its PDUFA date for Plecanatide.
Synergy Pharmaceuticals Inc (SGYP) Moves Closer To Expanding Plecanatide Label
Synergy Pharmaceuticals Inc (NASDAQ:SGYP) has provided an update on topline results from a Phase 3 study of its candidate plecanatide.
Do Hedge Funds Love Synergy Pharmaceuticals Inc (SGYP)?
The Insider Monkey team has completed processing the quarterly 13F filings for the September quarter submitted by the hedge funds and other money managers included in our extensive database.
Synergy Pharmaceuticals Inc (SGYP) Stock Heading Upward On Data Release
Synergy Pharmaceuticals Inc (NASDAQ:SGYP) is having a relatively strong day in the market today, and for good reason. The company released new data with regard to Plecanatide, its lead candidate.
Billionaire Hedge Funds
